The Broad Institute of Harvard and MIT has adopted Genedata’s Screener® for small molecule screening. The Screener will be used in the institute’s contribution to the Molecular Libraries and Imaging Initiative funded by the NIH. This NIH program for medical research, composed of nine institutions, conducts high-throughput biological studies of diverse small molecules to advance new drug discoveries.
Researchers at the Broad Institute are using Screener’s Assay Analyzer and Condoseo modules. Assay Analyzer captures data from diverse plate readers and processes them based on predefined business rules. Condoseo fits dose-response curves for IC50 determination in validation and assay panel screens.